retatrutide fda approval timeline Want to learn more about the GLP-3 called retatrutide? Not yet approved but soon. A weight loss game changer FDA approves Retatrutide this year?
Description
The bridge program changes that
Once targeted at diabetes, they are now fueling a global shift in obesity treatment, transforming lives and creating a multi-billion dollar market

If you prefer name-brand medications, MedVi offers Ozempic and Wegovy at $795 for the first month and $995 per month for refills

Lancet (1966) 2:7279

These information is proprietary

GLP-1 medications were in severe shortage from late 2022 through early 2025 because demand outstripped manufacturing capacity